CIK: 0001910264 · Show all filings
Period: Q1 2022 (← Previous) (Next →)
Filing Date: May 10, 2022
Total Value ($000): $195,335 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| DSGN | DESIGN THERAPEUTICS INC | 5,626,476 | $90,868 | 46.5% | $17.17 | -10.8% | COM | 25056L103 |
| ACLX | ARCELLX INC. | 5,500,007 | $77,110 | 39.5% | $16.72 | 0.0% | COMMON STOCK | 03940C100 |
| — | EFFECTOR THERAPEUTICS INC | 6,822,114 | $27,357 | 14.0% | $8.28 | — | COM | 28202V108 |